Review

recombinant tl1a (R&D Systems)

R&D Systems is a verified supplier

R&D Systems manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

R&D Systems recombinant tl1a

Fig. 4 Administration of <t>TL1A</t> directly induces features of necroptosis. (A) HBE cells were treated with BV6 (0.5 µM) and zVAD-fmk (20 µM) for 2 h, followed by stimulation with TL1A for 18 h. Viability was determined by CCK8 (n = 3). (B) The dosing regimen of <t>recombinant</t> protein TL1A. (C) Total number of cells and total protein content in BALF (n = 4). (D) Western blot analysis of p-RIPK3, t-RIPK3, p-MLKL, and t-MLKL in lungs of mice (n = 3). (E) Representative photomicrographs for lung paraffin sections from mice stained with H&E, PAS, and Masson staining, along with quantification of inflammation scores, PAS-positive cells, and collagen deposition around the airways (n = 5–8). Bars = 50 μm.*p < 0.05, **p < 0.01, ***p < 0.001

Recombinant Tl1a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+tl1a/Recombinant+Mouse+TL1A%2FTNFSF15+Protein/pm38987753-53-13-15
Average 92 stars, based on 5 article reviews

recombinant tl1a - by Bioz Stars, 2026-09

92/100 stars

Images

1) Product Images from "Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma."

Article Title: Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma.

Journal: Respiratory research

doi: 10.1186/s12931-024-02900-4

Fig. 4 Administration of TL1A directly induces features of necroptosis. (A) HBE cells were treated with BV6 (0.5 µM) and zVAD-fmk (20 µM) for 2 h, followed by stimulation with TL1A for 18 h. Viability was determined by CCK8 (n = 3). (B) The dosing regimen of recombinant protein TL1A. (C) Total number of cells and total protein content in BALF (n = 4). (D) Western blot analysis of p-RIPK3, t-RIPK3, p-MLKL, and t-MLKL in lungs of mice (n = 3). (E) Representative photomicrographs for lung paraffin sections from mice stained with H&E, PAS, and Masson staining, along with quantification of inflammation scores, PAS-positive cells, and collagen deposition around the airways (n = 5–8). Bars = 50 μm.*p < 0.05, **p < 0.01, ***p < 0.001

Figure Legend Snippet: Fig. 4 Administration of TL1A directly induces features of necroptosis. (A) HBE cells were treated with BV6 (0.5 µM) and zVAD-fmk (20 µM) for 2 h, followed by stimulation with TL1A for 18 h. Viability was determined by CCK8 (n = 3). (B) The dosing regimen of recombinant protein TL1A. (C) Total number of cells and total protein content in BALF (n = 4). (D) Western blot analysis of p-RIPK3, t-RIPK3, p-MLKL, and t-MLKL in lungs of mice (n = 3). (E) Representative photomicrographs for lung paraffin sections from mice stained with H&E, PAS, and Masson staining, along with quantification of inflammation scores, PAS-positive cells, and collagen deposition around the airways (n = 5–8). Bars = 50 μm.*p < 0.05, **p < 0.01, ***p < 0.001

Techniques Used: Recombinant, Western Blot, Staining

Fig. 5 TL1A-induced necroptosis promotes asthma inflammation. (A) OVA-induced asthma mouse model experimental scheme and recombinant pro tein TL1A dosing schedule. (B) Total number of cells and total protein content in BALF (n = 4). (C) Western blot analysis of p-RIPK3, t-RIPK3, p-MLKL, and t-MLKL in lungs mice (n = 3). (D) Representative photomicrographs for lung paraffin sections from mice stained with H&E, PAS, and Masson staining, along with quantification of inflammation scores, PAS-positive cells, and collagen deposition around the airways (n = 5–8). Bars = 50 μm.*p < 0.05, **p < 0.01, ***p < 0.001

Figure Legend Snippet: Fig. 5 TL1A-induced necroptosis promotes asthma inflammation. (A) OVA-induced asthma mouse model experimental scheme and recombinant pro tein TL1A dosing schedule. (B) Total number of cells and total protein content in BALF (n = 4). (C) Western blot analysis of p-RIPK3, t-RIPK3, p-MLKL, and t-MLKL in lungs mice (n = 3). (D) Representative photomicrographs for lung paraffin sections from mice stained with H&E, PAS, and Masson staining, along with quantification of inflammation scores, PAS-positive cells, and collagen deposition around the airways (n = 5–8). Bars = 50 μm.*p < 0.05, **p < 0.01, ***p < 0.001

Techniques Used: Recombinant, Western Blot, Staining

Fig. 6 TL1A-induced necroptosis affects airway epithelial intercellular adhesion. (A) Volcano plot of RNA-seq from OVA-treated lung tissues between MLKL WT (n = 3) and knockout (n = 3) mice. (P < 0.05, log|FC|≥1) (B) Bubble map of KEGG pathway enrichment. (C) HBE cells were transfected with siTL1A and then stimulated by TSZ for 4 h. Occludin and zonulin-1 (ZO-1) expression were determined by Western blot (n = 3). (D) Representative images of MU C5AC, ZO-1, and occludin immunohistochemical staining in lungs of mice (n = 5). (E) Western blot analysis of occludin and ZO-1 in lungs of mice (n = 3). (F) Representative images of MUC5AC, ZO-1, and occludin immunohistochemical staining in lungs of mice (n = 5). (G) Western blot analysis of occludin and ZO-1 in lungs of mice (n = 3). Bars = 50 μm.*p < 0.05, **p < 0.01, ***p < 0.001

Figure Legend Snippet: Fig. 6 TL1A-induced necroptosis affects airway epithelial intercellular adhesion. (A) Volcano plot of RNA-seq from OVA-treated lung tissues between MLKL WT (n = 3) and knockout (n = 3) mice. (P < 0.05, log|FC|≥1) (B) Bubble map of KEGG pathway enrichment. (C) HBE cells were transfected with siTL1A and then stimulated by TSZ for 4 h. Occludin and zonulin-1 (ZO-1) expression were determined by Western blot (n = 3). (D) Representative images of MU C5AC, ZO-1, and occludin immunohistochemical staining in lungs of mice (n = 5). (E) Western blot analysis of occludin and ZO-1 in lungs of mice (n = 3). (F) Representative images of MUC5AC, ZO-1, and occludin immunohistochemical staining in lungs of mice (n = 5). (G) Western blot analysis of occludin and ZO-1 in lungs of mice (n = 3). Bars = 50 μm.*p < 0.05, **p < 0.01, ***p < 0.001

Techniques Used: RNA Sequencing, Knock-Out, Transfection, Expressing, Western Blot, Immunohistochemical staining, Staining

Fig. 7 TL1A-induced necroptosis impacts cell junction molecules via NF-kB activation. (A) Human protein-protein interaction (PPI) network of necrop tosis, NF-κB, and cell adhesion molecules. (B) Mouse PPI network of necroptosis, NF-κB, and cell adhesion molecules. (C) HBE cells were transfected with siTL1A and then stimulated by TSZ for 4 h. Phosphorylation of p65 and IκBα expression were determined by Western blot. (D, E) Western blot analysis of p-p65, p65, p-IκBα, and IκBα in lungs of mice. (F) HBE cells were treated with the IκBα inhibitor BAY 11-7082 for 1 h before TSZ for 4 h. The expression of p-p65, p-IκBα, ZO-1, and occludin was determined by Western blot. N = 3. *p < 0.05, **p < 0.01, ***p < 0.001

Figure Legend Snippet: Fig. 7 TL1A-induced necroptosis impacts cell junction molecules via NF-kB activation. (A) Human protein-protein interaction (PPI) network of necrop tosis, NF-κB, and cell adhesion molecules. (B) Mouse PPI network of necroptosis, NF-κB, and cell adhesion molecules. (C) HBE cells were transfected with siTL1A and then stimulated by TSZ for 4 h. Phosphorylation of p65 and IκBα expression were determined by Western blot. (D, E) Western blot analysis of p-p65, p65, p-IκBα, and IκBα in lungs of mice. (F) HBE cells were treated with the IκBα inhibitor BAY 11-7082 for 1 h before TSZ for 4 h. The expression of p-p65, p-IκBα, ZO-1, and occludin was determined by Western blot. N = 3. *p < 0.05, **p < 0.01, ***p < 0.001

Techniques Used: Activation Assay, Transfection, Phospho-proteomics, Expressing, Western Blot

Activity Assay:

Article Title: Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders
Article Snippet: .. Activity of recombinant protein: WT C57BL/6 mice, RAG2-deficient mice, and RAG2γc-deficient mice, were given 10 μg of recombinant mouse TL1A (R&D Systems, Minneapolis, MN) or PBS intratracheally on days 1 and 2 and sacrificed for analyses one day later on day 3. .. Ocean Ridge Biosciences (Deerfield Beach, FL) performed the RNAseq transcriptomic screen and analysis on the lungs of mice induced with TL1A, via Illumina HiSeq 2000 (NCBI SRA database BioProject # PRJNA735223).

Recombinant:

Article Title: A Novel Role for TL1A/DR3 in Protection Against Intestinal Injury and Infection
Article Snippet: Anti-CD4 (RM4–5), anti-CD25 (PC61.5) and anti-Foxp3 (FJK-16s) antibodies contained in a Mouse Regulatory T-cell Staining Kit were purchased from eBiosciences (San Diego, CA). .. Recombinant mouse TL1A was purchased from R&D Systems, Inc. (Minneapolis, MN). ..

Article Title: Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice.
Article Snippet: TL1A, as a master regulatory cytokine, plays a key role in the development of diverse T-cell-mediated inflammatory and autoimmune diseases.. Our study is to further understand the roles of TL1A in the pathogenic mechanism of psoriasis and to find a possible new therapeutic strategy in the treatment of psoriasis.. The direct effects of TL1A injection in mice skin and the therapeutic effects of TL1A blockade in imiquimod (IMQ)-induced psoriasis-like mouse model were researched in this study.

Article Title: TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses.
Article Snippet: Cell culture and in vitro Th cell differentiation In general, total spleen or LN cells, T cell subpopulations, B cell subpopulations, or bone marrow cells were prepared, isolated with Miltenyi beads or sorted by flow cytometry as indicated, and then cultured in RPMI 1640 medium containing 10% FCS, 100 mg/ml streptomycin, 100 U/ml penicillin G, 13 nonessential amino acids, 1 mM sodium pyruvate, 2.5 mM 2-ME, and other supplements as indicated. .. In some cases, recombinant mouse TL1A (aa 76–252; R&D Systems, Minneapolis, MN) was added to the culture. ..

Article Title: Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
Article Snippet: Recombinant mouse TL1A (R&D systems) was added at 10 ng/ml. .. Recombinant mouse TL1A (R&D systems) was added at 10 ng/ml. .. For DC-T cell co-culture studies, 104 bone marrow-derived DC were cultured with 105 OT-II or DR3 KO OT-II naïve CD4+ T cells per well and the indicated concentration of OVA323-339 peptide, with or without 10 μg/ml of mouse CTLA4/Fc (Chimerigen).

other:

Article Title: Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
Article Snippet: T-depleted APC were obtained by incubating spleen cell suspensions with anti-Thy1.1 for 10 min on ice followed by incubation with low-tox-M rabbit complement (Cedarlane Laboratories) for 30 min at 37° C. Cells were washed and incubated with 25 μg/ml of mitomycin C (Sigma) for 30 min at 37° C. c. T Cell Activation and Polarization For costimulation studies, CD4 or naïve CD4 cells were stimulated with platebound anti-CD3 mAb (5 μg/ml or at the indicated concentration, 145-2C11; BD Pharmingen) in the presence or absence of plate-bound anti-CD28 mAb (5 μg/ml) (37.51; BD Pharmingen).

Article Title: Nucleic acids encoding antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease
Article Snippet: T-depleted APC were obtained by incubating spleen cell suspensions with anti-Thy1.1 for 10 min on ice followed by incubation with low-tox-M rabbit complement (Cedarlane Laboratories) for 30 min at 37° C. Cells were washed and incubated with 25 μg/ml of mitomycin C (Sigma) for 30 min at 37° C. c. T Cell Activation and Polarization For costimulation studies, CD4+ or naïve CD4+ cells were stimulated with platebound anti-CD3 mAb (5 μg/ml or at the indicated concentration, 145-2C11; BD Pharmingen) in the presence or absence of plate-bound anti-CD28 mAb (5 μg/ml) (37.51; BD Pharmingen).

Injection:

Saline:

Image Search Results

Journal: Respiratory research

Article Title: Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma.

doi: 10.1186/s12931-024-02900-4

Figure Lengend Snippet: Fig. 4 Administration of TL1A directly induces features of necroptosis. (A) HBE cells were treated with BV6 (0.5 µM) and zVAD-fmk (20 µM) for 2 h, followed by stimulation with TL1A for 18 h. Viability was determined by CCK8 (n = 3). (B) The dosing regimen of recombinant protein TL1A. (C) Total number of cells and total protein content in BALF (n = 4). (D) Western blot analysis of p-RIPK3, t-RIPK3, p-MLKL, and t-MLKL in lungs of mice (n = 3). (E) Representative photomicrographs for lung paraffin sections from mice stained with H&E, PAS, and Masson staining, along with quantification of inflammation scores, PAS-positive cells, and collagen deposition around the airways (n = 5–8). Bars = 50 μm.*p < 0.05, **p < 0.01, ***p < 0.001

Article Snippet: The methods of asthma model construction, RIPK3 inhibitor GSK872 (Selleck, China) injection, and recombinant TL1A (R&D systems, USA) nasal administration were illustrated in the figures below.

Techniques: Recombinant, Western Blot, Staining

Journal: Respiratory research

Article Title: Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma.

doi: 10.1186/s12931-024-02900-4

Figure Lengend Snippet: Fig. 5 TL1A-induced necroptosis promotes asthma inflammation. (A) OVA-induced asthma mouse model experimental scheme and recombinant pro tein TL1A dosing schedule. (B) Total number of cells and total protein content in BALF (n = 4). (C) Western blot analysis of p-RIPK3, t-RIPK3, p-MLKL, and t-MLKL in lungs mice (n = 3). (D) Representative photomicrographs for lung paraffin sections from mice stained with H&E, PAS, and Masson staining, along with quantification of inflammation scores, PAS-positive cells, and collagen deposition around the airways (n = 5–8). Bars = 50 μm.*p < 0.05, **p < 0.01, ***p < 0.001

Techniques: Recombinant, Western Blot, Staining

Journal: Respiratory research

Article Title: Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma.

doi: 10.1186/s12931-024-02900-4

Figure Lengend Snippet: Fig. 6 TL1A-induced necroptosis affects airway epithelial intercellular adhesion. (A) Volcano plot of RNA-seq from OVA-treated lung tissues between MLKL WT (n = 3) and knockout (n = 3) mice. (P < 0.05, log|FC|≥1) (B) Bubble map of KEGG pathway enrichment. (C) HBE cells were transfected with siTL1A and then stimulated by TSZ for 4 h. Occludin and zonulin-1 (ZO-1) expression were determined by Western blot (n = 3). (D) Representative images of MU C5AC, ZO-1, and occludin immunohistochemical staining in lungs of mice (n = 5). (E) Western blot analysis of occludin and ZO-1 in lungs of mice (n = 3). (F) Representative images of MUC5AC, ZO-1, and occludin immunohistochemical staining in lungs of mice (n = 5). (G) Western blot analysis of occludin and ZO-1 in lungs of mice (n = 3). Bars = 50 μm.*p < 0.05, **p < 0.01, ***p < 0.001

Techniques: RNA Sequencing, Knock-Out, Transfection, Expressing, Western Blot, Immunohistochemical staining, Staining

Journal: Respiratory research

Article Title: Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma.

doi: 10.1186/s12931-024-02900-4

Figure Lengend Snippet: Fig. 7 TL1A-induced necroptosis impacts cell junction molecules via NF-kB activation. (A) Human protein-protein interaction (PPI) network of necrop tosis, NF-κB, and cell adhesion molecules. (B) Mouse PPI network of necroptosis, NF-κB, and cell adhesion molecules. (C) HBE cells were transfected with siTL1A and then stimulated by TSZ for 4 h. Phosphorylation of p65 and IκBα expression were determined by Western blot. (D, E) Western blot analysis of p-p65, p65, p-IκBα, and IκBα in lungs of mice. (F) HBE cells were treated with the IκBα inhibitor BAY 11-7082 for 1 h before TSZ for 4 h. The expression of p-p65, p-IκBα, ZO-1, and occludin was determined by Western blot. N = 3. *p < 0.05, **p < 0.01, ***p < 0.001

Techniques: Activation Assay, Transfection, Phospho-proteomics, Expressing, Western Blot

TL1A induces mucus production when administered in isolation into the airways. (A) Schematic representation of the protocol used. Briefly, C57BL/6 mice were induced with 10μg of recombinant TL1A i.t. on two successive days. Mice were euthanized 24h after the last i.t. injection, and lungs were harvested for RNAseq analysis, PAS, ClcA1 and MUC5AC stains. (B) Heatmap of the top differentially regulated genes involved in mucus production, upregulated in the lungs of TL1A-induced mice. (C) Top panel: PAS stain of mucus produced in the lungs and quantified using Image Pro Premier and graphed as %PAS+ bronchial epithelial cells per lobe (right panel). Mid and Lower panels: Immunofluorescence stains of CLcA1 (green), MUC5AC (red) and nuclear DAPI (blue). All results representative of three experiments with four to six mice per group. **p < 0.005.

Journal: Frontiers in Immunology

Article Title: Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders

doi: 10.3389/fimmu.2021.692127

Figure Lengend Snippet: TL1A induces mucus production when administered in isolation into the airways. (A) Schematic representation of the protocol used. Briefly, C57BL/6 mice were induced with 10μg of recombinant TL1A i.t. on two successive days. Mice were euthanized 24h after the last i.t. injection, and lungs were harvested for RNAseq analysis, PAS, ClcA1 and MUC5AC stains. (B) Heatmap of the top differentially regulated genes involved in mucus production, upregulated in the lungs of TL1A-induced mice. (C) Top panel: PAS stain of mucus produced in the lungs and quantified using Image Pro Premier and graphed as %PAS+ bronchial epithelial cells per lobe (right panel). Mid and Lower panels: Immunofluorescence stains of CLcA1 (green), MUC5AC (red) and nuclear DAPI (blue). All results representative of three experiments with four to six mice per group. **p < 0.005.

Article Snippet: Activity of recombinant protein: WT C57BL/6 mice, RAG2-deficient mice, and RAG2γc-deficient mice, were given 10 μg of recombinant mouse TL1A (R&D Systems, Minneapolis, MN) or PBS intratracheally on days 1 and 2 and sacrificed for analyses one day later on day 3.

Techniques: Isolation, Recombinant, Injection, Staining, Produced, Immunofluorescence

Interrupting TL1A/DR3 signaling decreases mucus production in allergen-induced asthma. (A) Schematic representation of protocol used. Briefly, WT littermates and DR3-deficient mice on the C57BL/6 x 129 background were sensitized i.n. on day 0, 7, and 14 with 200 and 100 μg house dust mite extract protein in PBS, followed by chronic i.n. challenges of 50 μg of HDM protein administered twice a week for the following four weeks. Analyses were performed 24 hours after the last challenge. For neutralization of TL1A-DR3 interactions, mouse DR3-Fc or isotype control IgG were administered i.p. to WT C57BL/6 mice after the initial sensitization period starting at day 14 and were given every three days until the end of the experiment (100 μg/injection/mouse). (B) PAS stain of mucus produced in the lungs and quantified using Image Pro Premier. (C) Inflammation assessed by H&E stain (top panels), collagen deposition assessed by trichrome stain (middle panels), and smooth muscle hypertrophy assessed by αSMA immunofluorescence stain (red) (bottom panels) on lung biopsies of WT C57BL/6 mice after treatment with either IgG or DR3-Fc. Quantifications for each parameter, completed using Image Pro Premier, are shown to the right, including untreated WT C57BL/6 and DR3 -/- mice (images not shown). All results representative of three experiments with five mice per group. *p < 0.05, ** < 0.005, ***p < 0.0005, ****p < 0.00005.

Journal: Frontiers in Immunology

Article Title: Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders

doi: 10.3389/fimmu.2021.692127

Figure Lengend Snippet: Interrupting TL1A/DR3 signaling decreases mucus production in allergen-induced asthma. (A) Schematic representation of protocol used. Briefly, WT littermates and DR3-deficient mice on the C57BL/6 x 129 background were sensitized i.n. on day 0, 7, and 14 with 200 and 100 μg house dust mite extract protein in PBS, followed by chronic i.n. challenges of 50 μg of HDM protein administered twice a week for the following four weeks. Analyses were performed 24 hours after the last challenge. For neutralization of TL1A-DR3 interactions, mouse DR3-Fc or isotype control IgG were administered i.p. to WT C57BL/6 mice after the initial sensitization period starting at day 14 and were given every three days until the end of the experiment (100 μg/injection/mouse). (B) PAS stain of mucus produced in the lungs and quantified using Image Pro Premier. (C) Inflammation assessed by H&E stain (top panels), collagen deposition assessed by trichrome stain (middle panels), and smooth muscle hypertrophy assessed by αSMA immunofluorescence stain (red) (bottom panels) on lung biopsies of WT C57BL/6 mice after treatment with either IgG or DR3-Fc. Quantifications for each parameter, completed using Image Pro Premier, are shown to the right, including untreated WT C57BL/6 and DR3 -/- mice (images not shown). All results representative of three experiments with five mice per group. *p < 0.05, ** < 0.005, ***p < 0.0005, ****p < 0.00005.

Techniques: Neutralization, Control, Injection, Staining, Produced, Immunofluorescence

TL1A muco-secretory activity is dependent on IL13/IL4Rα signaling. (A) Schematic representation of the protocol used, as previously described in <xref ref-type=

Figure 1 . (B) Top panel: PAS stain of mucus produced in the lungs and quantified using Image Pro Premier (right panel). Mid and Lower panels: Immunofluorescence stains of CLcA1 (green), MUC5AC (red) and nuclear DAPI (blue). (C) Inflammation assessed by H&E stain (top panels), collagen deposition assessed by trichrome stain (middle panels), and smooth muscle hypertrophy assessed by αSMA immunofluorescence stain (red) (bottom panels) on lung biopsies of BALB/c and IL4Rα-deficient mice induced with PBS or TL1A. Quantification for each parameter is done using Image Pro Premier. All results representative of three experiments with four to six mice per group. ns, not significant, *p < 0.05, ** < 0.005. " width="100%" height="100%">

Journal: Frontiers in Immunology

Article Title: Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders

doi: 10.3389/fimmu.2021.692127

Figure Lengend Snippet: TL1A muco-secretory activity is dependent on IL13/IL4Rα signaling. (A) Schematic representation of the protocol used, as previously described in Figure 1 . (B) Top panel: PAS stain of mucus produced in the lungs and quantified using Image Pro Premier (right panel). Mid and Lower panels: Immunofluorescence stains of CLcA1 (green), MUC5AC (red) and nuclear DAPI (blue). (C) Inflammation assessed by H&E stain (top panels), collagen deposition assessed by trichrome stain (middle panels), and smooth muscle hypertrophy assessed by αSMA immunofluorescence stain (red) (bottom panels) on lung biopsies of BALB/c and IL4Rα-deficient mice induced with PBS or TL1A. Quantification for each parameter is done using Image Pro Premier. All results representative of three experiments with four to six mice per group. ns, not significant, *p < 0.05, ** < 0.005.

Techniques: Activity Assay, Staining, Produced, Immunofluorescence

TL1A induces mucus production independently of adaptive immunity, bystander to IL13 production by ILC2. (A) Schematic representation of the protocol used, as previously described in <xref ref-type=

Figure 1 . (B) Top panel: PAS stain of mucus produced in the lungs of RAG -/- and RAGγc -/- mice induced with PBS or TL1A and quantified using Image Pro Premier (right graph). Lower panels: Immunofluorescence stains of MUC5AC (red) and nuclear DAPI (blue). (C) DR3 staining on ILC2 assessed by flow cytometry (DR3 in blue and Isotype in red). (D) Number of lung ILC2 in the left lobe of RAG -/- mice induced with TL1A. (E) IL13 levels assessed by ELISA, in the supernatants of ILC2 cultured in the presence of IL2, IL7, and IL33 and stimulated with or without TL1A. All results representative of three experiments with four to six mice per group, or three individual replicate cultures. *p < 0.05, **p < 0.005. " width="100%" height="100%">

Journal: Frontiers in Immunology

Article Title: Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders

doi: 10.3389/fimmu.2021.692127

Figure Lengend Snippet: TL1A induces mucus production independently of adaptive immunity, bystander to IL13 production by ILC2. (A) Schematic representation of the protocol used, as previously described in Figure 1 . (B) Top panel: PAS stain of mucus produced in the lungs of RAG -/- and RAGγc -/- mice induced with PBS or TL1A and quantified using Image Pro Premier (right graph). Lower panels: Immunofluorescence stains of MUC5AC (red) and nuclear DAPI (blue). (C) DR3 staining on ILC2 assessed by flow cytometry (DR3 in blue and Isotype in red). (D) Number of lung ILC2 in the left lobe of RAG -/- mice induced with TL1A. (E) IL13 levels assessed by ELISA, in the supernatants of ILC2 cultured in the presence of IL2, IL7, and IL33 and stimulated with or without TL1A. All results representative of three experiments with four to six mice per group, or three individual replicate cultures. *p < 0.05, **p < 0.005.

Techniques: Staining, Produced, Immunofluorescence, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Cell Culture

Graphical Abstract. Upon epithelial injury, such as exposure to allergens, TL1A is produced and acts on ILC2 via DR3 to promote IL13 secretion, leading to mucus production. Created with BioRender.com .

Journal: Frontiers in Immunology

Article Title: Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders

doi: 10.3389/fimmu.2021.692127

Figure Lengend Snippet: Graphical Abstract. Upon epithelial injury, such as exposure to allergens, TL1A is produced and acts on ILC2 via DR3 to promote IL13 secretion, leading to mucus production. Created with BioRender.com .

Techniques: Produced

Fibroblast-selective DR3 deficiency results in severe disease activity: ( A – D ) Percent body weight loss, stool consistency, stool blood, and composite disease activity index are shown for the adoptive transfer model of colitis, at indicated time points for transfers of naïve Tl1a-Tg T cells into Rag −/− , Rag −/− Dr3 −/− , or Rag −/− Dr3 ∆Col1a2 mice. Data are represented as means ± SEM; * indicates p < 0.05, ** p < 0.01 Rag −/− Dr3 −/− vs Rag −/− ; # indicates p < 0.05 Rag −/− Dr3 −/− vs Rag −/− Dr3 ∆Col1a2 ; n = 9–10 mice per group. ( E – F ) Representative gross colonic specimens, quantitated macroscopic pathology scores, and colon lengths; representative H&E cecal sections and quantitated histopathological scores are shown; * indicates p < 0.05, ** p < 0.01. Pooled data of 3 independent experiments are represented.

Journal: Scientific Reports

Article Title: Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo

doi: 10.1038/s41598-020-75168-5

Figure Lengend Snippet: Fibroblast-selective DR3 deficiency results in severe disease activity: ( A – D ) Percent body weight loss, stool consistency, stool blood, and composite disease activity index are shown for the adoptive transfer model of colitis, at indicated time points for transfers of naïve Tl1a-Tg T cells into Rag −/− , Rag −/− Dr3 −/− , or Rag −/− Dr3 ∆Col1a2 mice. Data are represented as means ± SEM; * indicates p < 0.05, ** p < 0.01 Rag −/− Dr3 −/− vs Rag −/− ; # indicates p < 0.05 Rag −/− Dr3 −/− vs Rag −/− Dr3 ∆Col1a2 ; n = 9–10 mice per group. ( E – F ) Representative gross colonic specimens, quantitated macroscopic pathology scores, and colon lengths; representative H&E cecal sections and quantitated histopathological scores are shown; * indicates p < 0.05, ** p < 0.01. Pooled data of 3 independent experiments are represented.

Article Snippet: The plate was then incubated at 37 °C and 5% CO 2 for 1 h. After collagen polymerization, 1.0 mL of culture medium, with/without mouse recombinant Tl1a (R&D Systems, Minneapolis, MN) at a concentration 100 ng/mL, or ROCK inhibitor Y27632 (Stemcell Technologies, Cambridge, MA) at a concentration 25 μM , was added to the top of each collagen gel lattice.

Techniques: Activity Assay, Adoptive Transfer Assay

Transcriptomic analysis of Tl1a-stimulated intestinal fibroblasts identifies cytoskeletal contraction-related genes and the Rho signaling pathway: ( A ) Heatmap generated from transcriptome analysis of isolated cecal fibroblasts from three individual mice shown as untreated (a, b, c) and Tl1a-treated (a + Tl1a, etc.) pairs; BRB array tools, (brb.nci.nih.gov/BRB-ArrayTools). ( B ) Independent validation cohort was used to confirm several genes in the index group; matched pairs displayed as untreated (ut) or TL1A-treated fibroblasts with direct increase in expression for each sample shown, * indicates p < 0.05. ( C ) Genetic ontology pathway enrichment of differentially expressed genes induced by TL1A in ( A ).

Journal: Scientific Reports

Article Title: Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo

doi: 10.1038/s41598-020-75168-5

Figure Lengend Snippet: Transcriptomic analysis of Tl1a-stimulated intestinal fibroblasts identifies cytoskeletal contraction-related genes and the Rho signaling pathway: ( A ) Heatmap generated from transcriptome analysis of isolated cecal fibroblasts from three individual mice shown as untreated (a, b, c) and Tl1a-treated (a + Tl1a, etc.) pairs; BRB array tools, (brb.nci.nih.gov/BRB-ArrayTools). ( B ) Independent validation cohort was used to confirm several genes in the index group; matched pairs displayed as untreated (ut) or TL1A-treated fibroblasts with direct increase in expression for each sample shown, * indicates p < 0.05. ( C ) Genetic ontology pathway enrichment of differentially expressed genes induced by TL1A in ( A ).

Techniques: Generated, Isolation, Biomarker Discovery, Expressing

Inhibition of Rho kinase pathway modulates morphology and function of intestinal fibroblasts: ( A ) Gap closure assay and morphology of migrating intestinal fibroblasts isolated from three individual Tl1a-Tg mice, in the presence (or absence) of 25uM ROCK inhibitor Y27632, shown as treated and un-treated pairs. Blue arrow denotes direction of migration with solid vs dotted line highlighting cell extensions at migrating front; upper panels 100× objective, lower panels 200× objective. ( B ) Collagen contraction assay of intestinal fibroblasts isolated and treated as in ( A ). ( C ) Collagen contraction assay of WT or DR3 − / − intestinal fibroblasts treated with 100 ng/mL mouse recombinant Tl1a, 25uM ROCK inhibitor Y27632, or both. Data normalized to genotype control with bars representative of means; * indicates p < 0.05, ** p < 0.01.

Journal: Scientific Reports

Article Title: Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo

doi: 10.1038/s41598-020-75168-5

Figure Lengend Snippet: Inhibition of Rho kinase pathway modulates morphology and function of intestinal fibroblasts: ( A ) Gap closure assay and morphology of migrating intestinal fibroblasts isolated from three individual Tl1a-Tg mice, in the presence (or absence) of 25uM ROCK inhibitor Y27632, shown as treated and un-treated pairs. Blue arrow denotes direction of migration with solid vs dotted line highlighting cell extensions at migrating front; upper panels 100× objective, lower panels 200× objective. ( B ) Collagen contraction assay of intestinal fibroblasts isolated and treated as in ( A ). ( C ) Collagen contraction assay of WT or DR3 − / − intestinal fibroblasts treated with 100 ng/mL mouse recombinant Tl1a, 25uM ROCK inhibitor Y27632, or both. Data normalized to genotype control with bars representative of means; * indicates p < 0.05, ** p < 0.01.

Techniques: Inhibition, Isolation, Migration, Contraction Assay, Recombinant, Control

Review

recombinant tl1a (R&D Systems)

Structured Review

Images

1) Product Images from "Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma."

Related Articles

Activity Assay:

Recombinant:

other:

Injection:

Saline:

Similar Products

Image Search Results